PAR 1.92% 25.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-1736

  1. 471 Posts.
    lightbulb Created with Sketch. 209
    Coppo's report today (Mon 21/06/2021) on the approvals for Phase 2 clinical trial treating MPS-VI subjects in Brazil with PPS announced on Friday from the great man himself Richard Coppleson who is also a loyal LT SH too! wink.png

    https://hotcopper.com.au/data/attachments/3288/3288134-53e11b8d40a0ddd264966a500336d822.jpg
    GLTA LTSHs & PLS DYOR!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.005(1.92%)
Mkt cap ! $89.19M
Open High Low Value Volume
26.5¢ 26.5¢ 25.5¢ $61.58K 238.1K

Buyers (Bids)

No. Vol. Price($)
2 62473 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 50000 1
View Market Depth
Last trade - 16.10pm 29/05/2024 (20 minute delay) ?
Last
26.0¢
  Change
-0.005 ( 1.07 %)
Open High Low Volume
26.5¢ 26.5¢ 25.5¢ 105880
Last updated 15.59pm 29/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.